Phase II Study of S‐1 and Paclitaxel Combination Therapy in Patients with Previously Treated Non‐Small Cell Lung Cancer

LESSONS LEARNED. In terms of efficacy and safety, good results were obtained with S‐1 and paclitaxel (PTX) combination therapy. The findings suggest that S‐1 and PTX combination therapy is a feasible treatment option in patients with previously treated non‐small cell lung cancer. BACKGROUND. Althoug...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
الحاوية / القاعدة:Oncologist
المؤلفون الرئيسيون: Chihara, Yusuke, Yoshimura, Akihiro, Date, Koji, Takemura, Yoshizumi, Tamiya, Nobuyo, Kohno, Yoshihito, Imabayashi, Tatsuya, Takeuchi, Mayumi, Kaneko, Yoshiko, Yamada, Tadaaki, Ueda, Mikio, Arimoto, Taichiro, Uchino, Junji, Iwasaki, Yoshinobu, Takayama, Koichi
التنسيق: Artigo
اللغة:Inglês
منشور في: John Wiley & Sons, Inc. 2019
الموضوعات:
Clinical Trial Results
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC6693719/
https://ncbi.nlm.nih.gov/pubmed/31040252
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2019-0290
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة